Clinical Trial Update: Clinical and Genetic Studies of Li-Fraumeni Syndrome

View source ↗

Summary

Ongoing clinical and genetic studies on Li-Fraumeni syndrome, a TP53 mutation–associated cancer predisposition, with recruitment currently open.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Li-fraumeni Syndrome
• Neoplasms

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Li-Fraumeni Syndrome, Neoplasms | Status: RECRUITING